Vicore Presentation on May 19 at 13:00
Patient insights to shape development of a dCBT for IPF patients
C21 shows promise against COVID-19 where other drugs have failed
Idiopathic Pulmonary Fibrosis: 5 Things to Know
Top line data on the ATTRACT study
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients